alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 18,376–18,400 of 27,380 studies, newest first · page 736 of 1096.

October 2013 16

  1. 2013-10-01

    Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects

    ✓ Peer-reviewed Drug development Mayo Clinic proceedings

    Key finding: In patients without baseline cognitive dysfunction, short-term data are most compatible with no adverse effect of statins on cognition, and long-term data may support a beneficial role for statins in the prevention of dementia. +2 more findings

    Full summary, score breakdown and related studies → Original source

  2. 2013-10-01

    Epidemiology and etiology of Alzheimer's disease: from genetic to non-genetic factors

    ✓ Peer-reviewed Genetics Current Alzheimer research

    Key finding: Epidemiologic researches revealed that genetic factors played a decisive role in the development of both early-onset AD (EOAD) and late-onset AD (LOAD).

    Full summary, score breakdown and related studies → Original source

  3. 2013-10-01

    Cerebrospinal fluid secretion by the choroid plexus

    ✓ Peer-reviewed Tau biomarkers Physiological reviews

    Key finding: Significant emphasis is placed on the concept of isotonic fluid transport across epithelia, as there is still surprisingly little consensus on the basic biophysics of this phenomenon.

    Full summary, score breakdown and related studies → Original source

  4. 2013-10-01

    Childhood maltreatment and psychopathology: A case for ecophenotypic variants as clinically and neurobiologically distinct subtypes

    ✓ Peer-reviewed Hippocampus size on brain scans The American journal of psychiatry

    Key finding: Phenotypic expression of psychopathology may be strongly influenced by exposure to maltreatment, leading to a constellation of ecophenotypes. +3 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2013-10-01

    What is family-centered care for nursing home residents with advanced dementia?

    ✓ Peer-reviewed End-of-life care American journal of Alzheimer's disease and other dementias

    Key finding: Family members of NH residents (N = 16) with advanced dementia participated in semistructured qualitative interviews that inquired about overall NH experience, communication, surrogate decision making, emotional reaction, and recommendations for improvement.

    Full summary, score breakdown and related studies → Original source

  6. 2013-10-01

    Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials

    ✓ Peer-reviewed End-of-life care Aging and disease

    Key finding: Numerous clinical trials have so far been unable to identify another neuroprotective agent. +4 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2013-10-01

    Longitudinal differences in cognitive functioning among older adults with and without heart failure

    ✓ Peer-reviewed Prevention trials Journal of aging and health

    Key finding: The results indicate that cognitive difficulties in memory and speed may occur prior to a HF diagnosis, while those with HF may experience steeper declines in reasoning as measured by word series test. +1 more finding

    Full summary, score breakdown and related studies → Original source

  8. 2013-10-01

    Plasma proteomics for the identification of Alzheimer disease

    ✓ Peer-reviewed Risk genes beyond APOE Alzheimer disease and associated disorders

    Key finding: Significant proteins to differentiate between the CON and AD dementia groups were identified in a comprehensive panel of 107 plasma analytes in the training sample; the accuracy in differentiating these 2 groups was explored in the test sample. +2 more findings

    Full summary, score breakdown and related studies → Original source

  9. 2013-10-01

    Priority issues in women's mental health

    ✓ Peer-reviewed Risk factors World Psychiatry

    Key finding: The role of primary health care has been studied in several sites and the results are promising, with an emphasis on the usefulness of community support and non-pharmacological interventions 10, 11. +2 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2013-10-01

    Balancing Burdens and Benefits: Ethical Issues of Off‐Label Prescription Pharmaceutical Use

    ✓ Peer-reviewed Health systems and care delivery PM&R

    Key finding: He has even given a threshold outlining when the practice of medicine ends versus when the practice of unethical, non–institutional review board approved research begins. +3 more findings

    Full summary, score breakdown and related studies → Original source

  11. 2013-10-01

    Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion

    ✓ Peer-reviewed Lewy body dementia Science translational medicine

    Key finding: No significant loss of C9ORF72 expression was observed, and knockdown of the transcript was not toxic to cultured human motor neurons. +2 more findings

    Full summary, score breakdown and related studies → Original source

  12. 2013-10-01

    RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention

    ✓ Peer-reviewed Lewy body dementia Neuron

    Key finding: Induced pluripotent stem cell (iPSC)-differentiated neurons from C9ORF72 ALS patients revealed disease-specific (1) intranuclear GGGGCCexp RNA foci, (2) dysregulated gene expression, (3) sequestration of GGGGCCexp RNA binding protein ADARB2, and (4) susceptibility to excitotoxicity.

    Full summary, score breakdown and related studies → Original source

  13. 2013-10-01

    Cerebrospinal fluid Aβ42, phosphorylated Tau181, and resting-state functional connectivity

    ✓ Peer-reviewed Brain scans and imaging JAMA neurology

    Key finding: Both Aβ and tau pathology affect default mode network integrity before clinical onset of Alzheimer disease.

    Full summary, score breakdown and related studies → Original source

  14. 2013-10-01

    Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials

    ✓ Peer-reviewed Prevention and risk JAMA

    Key finding: During the CEE plus MPA intervention phase, the numbers of CHD cases were 196 for CEE plus MPA vs 159 for placebo (hazard ratio [HR], 1.18; 95% CI, 0.95-1.45) and 206 vs 155, respectively, for invasive breast cancer (HR, 1.24; 95% CI, 1.01-1.53). +2 more findings

    Full summary, score breakdown and related studies → Original source

  15. 2013-10-01

    Effects of memantine on clinical ratings, fluorodeoxyglucose positron emission tomography measurements, and cerebrospinal fluid assays in patients with moderate to severe Alzheimer dementia: a 24-week, randomized, clinical trial

    ✓ Peer-reviewed Treatments Journal of clinical psychopharmacology

    Key finding: In comparison with the placebo group, the memantine treatment group had significantly less cognitive decline on the Severe Impairment Battery and significantly less CMRgl declines in regions preferentially affected by AD. +2 more findings

    Full summary, score breakdown and related studies → Original source

  16. 2013-10-01

    Effect of cognitive reserve markers on Alzheimer pathologic progression

    ✓ Peer-reviewed Genetics Alzheimer disease and associated disorders

    Key finding: These findings remained unchanged after accounting for APOE 4, longitudinal missing data, and baseline cognitive performance.

    Full summary, score breakdown and related studies → Original source

September 2013 9

  1. 2013-09-28

    Rate of conversion from prodromal Alzheimer's disease to Alzheimer's dementia: a systematic review of the literature

    ✓ Peer-reviewed How common it is Dementia and geriatric cognitive disorders extra

    Key finding: Key message Extensive variation was observed in conversion rates due to the population sampled, diagnostic criteria, and duration, and because many studies did not account for loss to follow-up. +4 more findings

    Full summary, score breakdown and related studies → Original source

  2. 2013-09-27

    Gait speed in Parkinson disease correlates with cholinergic degeneration

    ✓ Peer-reviewed Digital health tools Neurology

    Key finding: Comorbid cortical cholinergic denervation is a more robust marker of slowing of gait in PD than nigrostriatal denervation alone. +4 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2013-09-27

    Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and γ-secretase-dependent intramembranous cleavage

    ✓ Peer-reviewed Risk genes beyond APOE The Journal of biological chemistry

    Key finding: Recently, TREM2 variants have been shown to be linked to late onset Alzheimer disease. +3 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2013-09-26

    Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo

    ✓ Peer-reviewed Drug development Neuron

    Key finding: They also suggest that immunotherapy specifically designed to block trans-cellular aggregate propagation will be a productive treatment strategy.

    Full summary, score breakdown and related studies → Original source

  5. 2013-09-25

    Functional screening in Drosophila identifies Alzheimer's disease susceptibility genes and implicates Tau-mediated mechanisms

    ✓ Peer-reviewed Genetics Human Molecular Genetics

    Key finding: Our results highlight cell adhesion pathways as important in Tau toxicity and AD susceptibility and demonstrate the power of model organism genetic screens for the functional follow-up of human GWAS.

    Full summary, score breakdown and related studies → Original source

  6. 2013-09-25

    Benzoate, a D-amino acid oxidase inhibitor, for the treatment of early-phase Alzheimer disease: a randomized, double-blind, placebo-controlled trial

    ✓ Peer-reviewed Treatments Biological psychiatry

    Key finding: Sodium benzoate substantially improved cognitive and overall functions in patients with early-phase AD. +2 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2013-09-24

    Maternal anxiety and infants' hippocampal development: timing matters

    ✓ Peer-reviewed Hippocampus size on brain scans Translational psychiatry

    Key finding: Regression analyses showed that antenatal maternal anxiety did not influence bilateral hippocampal volume at birth.

    Full summary, score breakdown and related studies → Original source

  8. 2013-09-23

    The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives

    ✓ Peer-reviewed Risk genes beyond APOE Biochimica et biophysica acta

    Key finding: This hypothesis maintains that gene inheritance defines an individual's baseline mitochondrial function; inherited and environmental factors determine rates at which mitochondrial function changes over time; and baseline mitochondrial function and mitochondrial change rates influence AD chronology. +4 more findings

    Full summary, score breakdown and related studies → Original source

  9. 2013-09-23

    Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials

    ✓ Peer-reviewed Cognitive tests and assessment PloS one

    Key finding: Huperzine A is a Chinese herb extract used for Alzheimer's disease. +3 more findings

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →